Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts (2024)

References

  1. Patterson, D. M., Nazarova, L. A. & Prescher, J. A. Finding the right (bioorthogonal) chemistry. ACS Chem. Biol. 9, 592–605 (2014).

    Article CAS PubMed Google Scholar

  2. Ramil, C. P. & Lin, Q. Bioorthogonal chemistry: strategies and recent developments. Chem. Commun. 49, 11007–11022 (2013).

    Article CAS Google Scholar

  3. Bertozzi, C. R. A decade of bioorthogonal chemistry. Acc. Chem. Res. 44, 651–653 (2011).

    Article CAS PubMed PubMed Central Google Scholar

  4. Koo, H. et al. Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. Angew. Chem. Int. Ed. 51, 11836–11840 (2012).

    Article CAS Google Scholar

  5. Devaraj, N. K., Thurber, G. M., Keliher, E. J., Marinelli, B. & Weissleder, R. Reactive polymer enables efficient in vivo bioorthogonal chemistry. Proc. Natl Acad. Sci. USA 109, 4762–4767 (2012).

    Article PubMed PubMed Central Google Scholar

  6. Komatsu, H., Shindo, Y., Oka, K., Hill, J. P. & Ariga, K. Ubiquinone-Rhodol (UQ-Rh) for fluorescence imaging of NAD(P)H through intracellular activation. Angew. Chem. Int. Ed. 53, 3993–3995 (2014).

    Article CAS Google Scholar

  7. Sletten, E. M. & Bertozzi, C. R. From mechanism to mouse: a tale of two bioorthogonal reactions. Acc. Chem. Res. 44, 666–676 (2011).

    Article CAS PubMed PubMed Central Google Scholar

  8. Saxon, E. & Bertozzi, C. R. Cell surface engineering by a modified Staudinger reaction. Science 287, 2007–2010 (2000).

    Article CAS PubMed Google Scholar

  9. Li, J. & Chen, P. R. Palladium-triggered deprotection chemistry for protein activation in living cells. Nature Chem. 6, 352–361 (2014).

    Article CAS Google Scholar

  10. Sasmal, P. K., Streu, C. N. & Meggers, E. Metal complex catalysis in living biological systems. Chem. Commun. 49, 1581–1587 (2013).

    Article CAS Google Scholar

  11. Unciti-Broceta, A., Johansson, E. M. V., Yusop, R. M., Sánchez-Martín, R. M. & Bradley, M. Synthesis of polystyrene microspheres and functionalization with Pd(0) nanoparticles to perform bioorthogonal organometallic chemistry in living cells. Nature Protoc. 7, 1207–1218 (2012).

    Article CAS Google Scholar

  12. Streu, C. & Meggers, E. Ruthenium-induced allylcarbamate cleavage in living cells. Angew. Chem. Int. Ed. 45, 5645–5648 (2006).

    Article CAS Google Scholar

  13. Yusop, R. M., Unciti-Broceta, A., Johansson, E. M. V., Sánchez-Martín, R. M. & Bradley, M. Palladium-mediated intracellular chemistry. Nature Chem. 3, 239–243 (2011).

    Article CAS Google Scholar

  14. Sasmal, P. K. et al. Catalytic azide reduction in biological environments. ChemBioChem. 13, 1116–1120 (2012).

    Article CAS PubMed Google Scholar

  15. Do, J. H., Kim, H. N., Yoon, J., Kim, J. S. & Kim, H-J. A rationally designed fluorescence turn-on probe for the gold(III) ion. Org. Lett. 12, 932–934 (2010).

    Article CAS PubMed Google Scholar

  16. Weiss, J. T. et al. Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach. Nature Commun. 5, 3277 (2014).

    Article CAS Google Scholar

  17. Yoon, H. J., Kuwabara, J., Kim, J-H. & Mirkin, C. A. Allosteric supramolecular triple-layer catalysts. Science 330, 66–69 (2010).

    Article CAS PubMed Google Scholar

  18. De, M., Ghosh, P. S. & Rotello, V. M. Applications of nanoparticles in biology. Adv. Mater. 20, 4225–4241 (2008).

    Article CAS Google Scholar

  19. Murphy, C. J. et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721–1730 (2008).

    Article CAS PubMed Google Scholar

  20. Boisselier, E. & Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38, 1759–1782 (2009).

    Article CAS PubMed Google Scholar

  21. Tonga, G. Y., Saha, K. & Rotello, V. M. Interfacing nanoparticles and biology new strategies for biomedicine. Adv. Mater. 26, 359–370 (2014).

    Article CAS PubMed Google Scholar

  22. Mout, R. & Rotello, V. M. Bio and nano working together: engineering the protein–nanoparticle interface. Isr. J. Chem. 53, 521–529 (2013).

    Article CAS Google Scholar

  23. Kim, B. et al. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nature Nanotech. 5, 465–472 (2010).

    Article CAS Google Scholar

  24. Ghosh, P. et al. Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J. Am. Chem. Soc. 132, 2642–2645 (2010).

    Article CAS PubMed PubMed Central Google Scholar

  25. Kim, C. K. et al. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J. Am. Chem. Soc. 131, 1360–1361 (2009).

    Article CAS PubMed PubMed Central Google Scholar

  26. Manea, F., Houillon, F. B., Pasquato, L. & Scrimin, P. Nanozymes: gold-nanoparticles-based transphosphorylation catalysts. Angew. Chem. Int. Ed. 43, 6165–6169 (2004).

    Article CAS Google Scholar

  27. Wang, Z. et al. Nanoparticle-based artificial RNA silencing machinery for antiviral therapy. Proc. Natl Acad. Sci. USA 109, 12387–12392 (2012).

    Article PubMed PubMed Central Google Scholar

  28. Pengo, P., Baltzer, L., Pasquato, L. & Scrimin, P. Substrate modulation of the activity of an artificial nanoesterase made of peptide-functionalized gold nanoparticles. Angew. Chem. Int. Ed. 46, 400–404 (2007).

    Article CAS Google Scholar

  29. Wei, H. & Wang, E. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. Chem. Soc. Rev. 42, 6060–6093 (2013).

    Article CAS PubMed Google Scholar

  30. Natalio, F. et al. Vanadium pentoxide nanoparticles mimic vanadium haloperoxidases and thwart biofilm formation. Nature Nanotech. 7, 530–535 (2012).

    Article CAS Google Scholar

  31. Hastings, C. J., Backlund, M. P., Bergman, R. G. & Raymond, K. N. Enzyme-like control of carbocation deprotonation regioselectivity in supramolecular catalysis of the Nazarov cyclization. Angew. Chem. Int. Ed. 50, 10570–10573 (2011).

    Article CAS Google Scholar

  32. Ghosh, S. & Isaacs, L. Biological catalysis regulated by cucurbit[7]uril molecular containers. J. Am. Chem. Soc. 132, 4445–4454 (2010).

    Article CAS PubMed Google Scholar

  33. Masson, E., Ling, X., Joseph, R., Kyeremeh-Mensah, L. & Lu, X. Cucurbituril chemistry: a tale of supramolecular success. RSC Adv. 2, 1213–1247 (2012).

    Article CAS Google Scholar

  34. Lee, J. W., Samal, S., Selvapalam, N., Kim, H-J. & Kim, K. Cucurbituril hom*ologues and derivatives: new opportunities in supramolecular chemistry. Acc. Chem. Res. 36, 621–630 (2003).

    Article CAS PubMed Google Scholar

  35. Kim, K. et al. Functionalized cucurbiturils and their applications. Chem. Soc. Rev. 36, 267–279 (2007).

    Article CAS PubMed Google Scholar

  36. Ambrogio, M. W., Thomas, C. R., Zhao, Y-L., Zink, J. I. & Stoddart, J. F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc. Chem. Res. 44, 903–913 (2011).

    Article CAS PubMed PubMed Central Google Scholar

  37. Kim, H. et al. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv. Mater. 22, 4280–4283 (2010).

    Article CAS PubMed Google Scholar

  38. Liu, S. et al. The cucurbit[n]uril family: prime components for self-sorting systems. J. Am. Chem. Soc. 127, 15959–15967 (2005).

    Article CAS PubMed Google Scholar

  39. Khashab, N. M. et al. pH-responsive mechanised nanoparticles gated by semirotaxanes. Chem. Commun. 5371–5373 (2009).

  40. Hong, R. et al. Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. J. Am. Chem. Soc. 126, 739–743 (2004).

    Article CAS PubMed Google Scholar

  41. Kim, C., Agasti, S. S., Zhu, Z., Isaacs, L. & Rotello, V. M. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nature Chem. 2, 962–966 (2010).

    Article CAS Google Scholar

  42. Angelos, S. et al. pH clock-operated mechanized nanoparticles. J. Am. Chem. Soc. 131, 12912–12914 (2009).

    Article CAS PubMed Google Scholar

  43. Alcaide, B., Almendros, P. & Alonso, J. M. A practical ruthenium-catalyzed cleavage of the allyl protecting group in amides, lactams, imides, and congeners. Chem. Eur. J. 12, 2874–2879 (2006).

    Article CAS PubMed Google Scholar

  44. Sasmal, P. K., Carregal-Romero, S., Parak, W. J. & Meggers, E. Light-triggered ruthenium-catalyzed allylcarbamate cleavage in biological environments. Organometallics 31, 5968–5970 (2012).

    Article CAS Google Scholar

  45. Zhu, Z-J. et al. Determination of the intracellular stability of gold nanoparticle monolayers using mass spectrometry. Anal. Chem. 84, 4321–4326 (2012).

    Article CAS PubMed PubMed Central Google Scholar

  46. Jeon, W. S. et al. Complexation of ferrocene derivatives by the cucurbit[7]uril host: a comparative study of the cucurbituril and cyclodextrin host families. J. Am. Chem. Soc. 127, 12984–12989 (2005).

    Article CAS PubMed Google Scholar

  47. Lineweaver, H. & Burk, D. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658–666 (1934).

    Article CAS Google Scholar

  48. Miller, D. J., Surfraz, M. B-U., Akhtar, M., Gani, D. & Allemann, R. K. Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity. Org. Biomol. Chem. 2, 671–688 (2004).

    Article CAS PubMed Google Scholar

  49. Verma, A. et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nature Mater. 7, 588–595 (2008).

    Article CAS Google Scholar

  50. Gu, Z., Biswas, A., Zhao, M. & Tang, Y. Tailoring nanocarriers for intracellular protein delivery. Chem. Soc. Rev. 40, 3638–3655 (2011).

    Article CAS PubMed Google Scholar

  51. Cai, S. X. et al. Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg. Med. Chem. Lett. 11, 39–42 (2001).

    Article CAS PubMed Google Scholar

  52. Saif, M. W., Choma, A., Salamone, S. J. & Chu, E. Pharmaco*kinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes. J. Natl Cancer Inst. 101, 1543–1552 (2009).

    Article CAS PubMed Google Scholar

  53. Longley, D. B., Harkin, D. P. & Johnston, P. G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nature Rev. 3, 330–338 (2003).

    CAS Google Scholar

  54. Wang, Z. J., Clary, K. N., Bergman, R. G., Raymond, K. N. & Toste, F. D. A supramolecular approach to combining enzymatic and transition metal catalysis. Nature Chem. 5, 100–103 (2013).

    Article CAS Google Scholar

  55. Marr, A. C. & Liu, S. Combining bio- and chemo-catalysis: from enzymes to cells, from petroleum to biomass. Trends Biotechnol. 29, 199–204 (2011).

    Article CAS PubMed Google Scholar

Download references

Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts (2024)

FAQs

What is bioorthogonal catalysis? ›

Bioorthogonal catalysis expands this chemistry employing catalytic reactions that natural enzymes cannot access. These reactions enable the creation of bioorthogonal 'factories' in living systems, for localized and controlled generation of drugs and imaging agents directly at the therapeutic site.

What is the catalytic activity of nanoparticles? ›

Nanomaterial-based catalysts are usually heterogeneous catalysts broken up into metal nanoparticles in order to enhance the catalytic process. Metal nanoparticles have high surface area, which can increase catalytic activity. Nanoparticle catalysts can be easily separated and recycled.

Are nanoparticles catalysts? ›

Nanocatalysts have many active sites on their surface, while enzymes have a small number of active sites, usually just only one. Thus, when nanoparticles are used as catalysts, signal generation at many active sites per nanoparticle may allow higher amplification [99].

What are metal nanoparticles in catalysis? ›

Metal nanoparticles are characterized by the highly reduced size, in a typical range of 1–10 nm, and the significantly enhanced catalytic performance; but they are subject to structural and chemical changes under the reaction conditions, primarily induced by the reactive gases at elevated temperatures.

What are the requirements for bioorthogonal chemistry? ›

This can be explained by numerous constraints encountered during the development of bioorthogonal reactions, some of which are: (1) reactions need to be robust, with high yields and fast rates at relatively low concentrations; (2) reactions need to take place in the physiological conditions at neutral pH; (3) reactants ...

What is the purpose of bioorthogonal chemistry? ›

Bioorthogonal chemistry involves selective biocompatible reactions between functional groups that are not normally present in biology. It has been used to probe biomolecules in living systems, and has advanced biomedical strategies such as diagnostics and therapeutics.

What are the disadvantages of nanoparticles in catalysts? ›

Once inside the body, they might catalyse reactions that are harmful. Toxic. substances could bind to them because of their large surface area to volume ratios, harming health if the nanoparticles do get into the body.

Why are nanoparticles used in catalytic converters? ›

However, the problem comes when the O2 concentration goes above the optimum level, leading to an oxide layer build-up that impedes reaction. Modern converters use nanoparticles because of the greater surface area they have for a given amount of material, on which the reaction can take place.

Why is catalytic activity associated with transition metals? ›

Transition elements exhibit variable valency to form intermediate compounds. Hence they act as a good catalyst. The catalytic activity of the transition metals and their compounds is described to their ability to adopt multiple oxidation states and their complexing ability.

What are the two advantages of nanoparticle catalysts? ›

Reduced Catalyst Amount: Nanoparticle catalysis generally requires a smaller amount of catalyst because their high activity can be achieved at lower catalyst concentrations. This not only reduces production costs, but also helps reduce waste generation and is beneficial to environmental protection.

Which property of nanoparticles makes them excellent catalysts? ›

Nanoparticles have a very high surface area to volume ratio and make excellent catalysts.

What are the risks of nanoparticles? ›

Nanoparticles can potentially move from the lungs to other organs such as the brain, the liver, the spleen and possibly the foetus in pregnant women. Data on these pathways is extremely limited but the actual number of particles that move from one organ to another can be considerable, depending on exposure time.

What is an example of a transition metal catalyst? ›

Transition metals such as iron, nickel, and copper are commonly used as heterogeneous catalysts in industrial processes. For example, iron is used in the Haber process to produce ammonia, nickel is used in the hydrogenation of vegetable oils, and copper is used in the oxidation of alcohols.

Which metal is used for nanoparticles? ›

The most commonly used metal nanoparticles in tissue engineering and biomedical applications are silver and gold nanoparticles with a small proportion of platinum nanoparticles [103–105].

How do nanomaterials are useful in catalysis? ›

Using Nanoparticles to Improve Catalytic Processes

The first is that, due to their small size, they have a greatly increased surface-to-volume ratio. This strongly increases the specific catalytic activity because the chemical reactions occur on the surface of the particle.

What is an example of bioorthogonal chemistry? ›

Staudinger Ligation. The earliest bioorthogonal reaction developed was the Staudinger ligation, a reaction based on the Staudinger reaction. In the Staudinger reaction, azides react with phosphines to form amines and phosphine oxides through an iminophosphorane intermediate.

What is bioorthogonal conjugation chemistry? ›

Bioorthogonal chemistry represents a class of high-yielding chemical reactions that proceed rapidly and selectively in biological environments without side reactions towards endogenous functional groups.

What are the 3 types of catalysis? ›

Catalysts can be categorized as hom*ogeneous, heterogeneous, or enzymatic. hom*ogeneous catalysts exist in the same phase as the reactants, whereas heterogeneous catalysts exist in a different phase than the reactants.

What is the meaning of bio catalysis? ›

Biocatalysis is the enzymatic transformation of chemical substrates into a target product molecule. The metabolic enzymes and secondary metabolism of microorganisms have been exploited for food and beverage preparation for thousands of years.

References

Top Articles
Latest Posts
Article information

Author: Tuan Roob DDS

Last Updated:

Views: 5836

Rating: 4.1 / 5 (42 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Tuan Roob DDS

Birthday: 1999-11-20

Address: Suite 592 642 Pfannerstill Island, South Keila, LA 74970-3076

Phone: +9617721773649

Job: Marketing Producer

Hobby: Skydiving, Flag Football, Knitting, Running, Lego building, Hunting, Juggling

Introduction: My name is Tuan Roob DDS, I am a friendly, good, energetic, faithful, fantastic, gentle, enchanting person who loves writing and wants to share my knowledge and understanding with you.